The Struggles of India’s Vaccine Giant

A real estate investor’s pursuit of cheap land has prompted a lawsuit against a compound in Arkansas that will test whether civil rights laws can stop a whites-only town from existing in America. Today, Debra Kamin, a New York Times investigative reporter, discusses the community ...  Show more

President Trump has begrudgingly accepted that artificial intelligence requires oversight and on Tuesday signed an executive order asking companies to voluntarily give the government access to new models before they’re released to the public. Tripp Mickle, who covers Silicon Vall ...  Show more

It's time to pay attention! We're not supposed to know about the politicization of lockdown policies, vaccine distribution, schools reopening ... and we're not supposed to say anything about any of it, but this is the time to be watching and taking notice more than ever. -- Today ...  Show more

Thejna John is a happy woman. Last year, the relapse of an acute form of blood cancer despite a bone marrow transplant, had made her doctors give up all hope.

In October, came a breakthrough. India approved the CAR T-Cell therapy, a revolutionary treatment for some form ...

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

Les vaccins contre le Covid-19 sont au centre de toutes les attentions. Ils sont l'espoir auquel se raccrochent les gouvernements du monde entier pour sortir de la crise sanitaire qui nous touche depuis un an. Si leur mise au point s'est faite en un temps record, en matière de ...